 bleeding
as primary measures of efficacy and safety.2-4 Such trials
have indeed established anticoagulation to be safe and

JOURNAL OF VASCULAR SURGERY
Volume 55, Number 5

effective, with major hemorrhage in 2% of patients5 and
3-month recurrence rates as low as 5.5%.6 However, the
importance of late manifestations of the postthrombotic
syndrome have been increasingly recognized